Girolamo Cirrincione Selected Research

Imatinib Mesylate (Gleevec)

1/2017

Interleukin 3- receptor targeted exosomes inhibit in vitro and in vivo Chronic Myelogenous Leukemia cell growth.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Girolamo Cirrincione Research Topics

Disease

8	Neoplasms (Cancer) 04/2022 - 03/2002
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 04/2012
3	Infections 12/2020 - 10/2017
3	Mesothelioma 09/2020 - 09/2013
2	Persistent Infection 01/2021 - 01/2019
2	Adenocarcinoma 03/2020 - 01/2020
2	Hepatocellular Carcinoma (Hepatoma) 04/2015 - 02/2007
1	Glioblastoma (Glioblastoma Multiforme) 04/2022
1	Triple Negative Breast Neoplasms 04/2022
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Pancreatic Diseases (Pancreatic Disease) 01/2020
1	Long Term Adverse Effects 01/2017
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2017
1	Lung Neoplasms (Lung Cancer) 01/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 04/2015
1	Phototoxic Dermatitis (Phototoxicity) 07/2011
1	Melanoma (Melanoma, Malignant) 07/2011
1	Leukemia 07/2011
1	Prostatic Neoplasms (Prostate Cancer) 02/2007
1	Kidney Neoplasms (Kidney Cancer) 04/2005

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 12/2020 - 02/2007
3	ThiadiazolesIBA 09/2020 - 01/2020
3	indoleIBA 09/2020 - 07/2019
3	Biological ProductsIBA 01/2020 - 09/2013
2	Phosphotransferases (Kinase)IBA 01/2021 - 04/2012
2	Gemcitabine FDA Link 09/2020 - 03/2020
1	EnzymesIBA 04/2022
1	topsentinIBA 01/2021
1	Ketoconazole (Nizoral)FDA LinkGeneric 01/2021
1	Itraconazole (Sporanox)FDA LinkGeneric 01/2021
1	Drug CombinationsIBA 09/2020
1	ThiophenesIBA 09/2020
1	NucleosidesIBA 09/2020
1	Focal Adhesion Protein-Tyrosine KinasesIBA 09/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020
1	ThiazolesIBA 01/2020
1	Virulence Factors (Pathogenicity Factors)IBA 01/2019
1	relebactamIBA 10/2017
1	Imipenem FDA Link 10/2017
1	Interleukin-3 Receptors (Interleukin 3 Receptor)IBA 01/2017
1	Imatinib Mesylate (Gleevec)FDA Link 01/2017
1	Small Interfering RNA (siRNA)IBA 01/2017
1	TubulinIBA 08/2016
1	IsoindolesIBA 08/2016
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2016
1	Photosensitizing Agents (Photosensitizers)IBA 09/2015
1	QuinolinesIBA 09/2015
1	PhosphatidylserinesIBA 04/2015
1	Aniline CompoundsIBA 11/2014
1	cinnolineIBA 11/2014
1	benzocycloheptapyridineIBA 09/2013
1	tyrosine receptor (receptor, tyrosine)IBA 04/2012
1	TriazenesIBA 04/2012
1	Dacarbazine (DIC)FDA LinkGeneric 07/2011
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2011
1	ChlorineIBA 04/2005
1	quinolineIBA 08/2003
1	Dihydrotachysterol (AT 10)IBA 03/2002

Therapy/Procedure

1	Indwelling Catheters (Indwelling Catheter) 01/2021
1	Therapeutics 09/2013